Shires Income (SHRS) Share Price, News & Analysis

Company Overview

Shires Income PLC is a closed ended equity mutual fund launched and managed by Aberdeen Fund Managers Limited. The fund is co-managed by Aberdeen Asset Managers Limited. It invests in the public equity markets of the United Kingdom. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in ordinary, convertible, and preference shares of companies. The fund employs fundamental analysis with a bottom-up stock picking approach with a focus on factors like management, business focus, balance sheet, corporate governance, financial ratios, market, peer group, and business prospects to create its portfolio. It benchmarks the performance of its portfolio against the FTSE All-Share Index (Total Return). Shires Income PLC was formed in 1929 and is domiciled in the United Kingdom.

Key Stats

• Today's Range: 233 to 237
• 50-Day Range: 231 to 246
• 52-Week Range: 207.95 to 253
• Volume: 68,519 shs
• Average Volume: 67,747 shs
• Market Capitalization: £97.63 million
• P/E Ratio: N/A
• Dividend Yield: 5.93%
• Price Target: N/A
• Consensus Rating: N/A

SHRS Stock Analysis - Frequently Asked Questions

How have SHRS shares performed this year?

Shires Income's stock was trading at GBX 226 at the beginning of the year. Since then, SHRS shares have increased by 4.4% and is now trading at GBX 236.
View the best growth stocks for 2024 here.

How do I buy shares of Shires Income?

Shares of SHRS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Shires Income own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Shires Income investors own include Galectin Therapeutics (GALT) and Esperion Therapeutics (ESPR).

Company Calendar

• Ex-Dividend for 10/31 Dividend: 10/03/2024
• Dividend Payable: 10/31/2024
• Today: 12/21/2024
• Ex-Dividend for 1/31 Dividend: 1/02/2025
• Dividend Payable: 1/31/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: N/A
• Current Symbol: LON:SHRS
• CUSIP: N/A
• CIK: N/A
• Web: www.shiresincome.co.uk
• Phone: 44-1224631999
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-1,470,000.00
• Net Margins: -216.15%
• Pretax Margin: N/A
• Return on Equity: -1.58%
• Return on Assets: -0.15%

Debt

• Debt-to-Equity Ratio: 17.90
• Current Ratio: 0.34
• Quick Ratio: 0.23

Sales & Book Value

• Annual Sales: £10.57 million
• Price / Sales: 9.24
• Cash Flow: GBX 4.37 per share
• Price / Cash Flow: 53.97
• Book Value: GBX 256 per share
• Price / Book: 0.92

Miscellaneous

• Outstanding Shares: 41,370,000
• Free Float: N/A
• Market Cap: £97.63 million
• Optionable: Not Optionable
• Beta: 0.86